Evolent Health, Inc. (EVH) Operating Margin
- Operating margin · 12 months: Value -20.39%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -20.39% | Operating income / revenue. Period ending 2026-06-30. $-427.50M ÷ $2.10B × 100 ≈ -20.39% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -427.50M USD | Operating Income (Loss) |
| Revenue | 2.10B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 291.90M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-427.50M | $2.10B | (m) | (m) | $291.90M | -20.39% |
| 2026-03-31 | $-419.12M | $1.89B | (m) | (m) | $298.27M | -22.19% |
| 2025-12-31 | $-410.14M | $1.88B | (m) | (m) | $303.87M | -21.86% |
| 2025-09-30 | $-20.50M | $2.05B | (m) | (m) | $278.91M | -1.00% |
| 2025-06-30 | $-37.66M | $2.20B | (m) | (m) | $268.38M | -1.71% |
| 2025-03-31 | $-28.70M | $2.40B | (m) | (m) | $262.36M | -1.20% |
| 2024-12-31 | $-40.48M | $2.55B | (m) | (m) | $263.05M | -1.58% |
| 2024-09-30 | $-43.24M | $2.46B | (m) | (m) | $296.78M | -1.75% |
| 2024-06-30 | $-44.91M | $2.35B | (m) | (m) | $326.28M | -1.91% |
| 2024-03-31 | $-74.27M | $2.18B | (m) | (m) | $347.49M | -3.41% |
| 2023-12-31 | $-71.21M | $1.96B | (m) | (m) | $358.11M | -3.63% |
| 2023-09-30 | $-51.74M | $1.79B | (m) | (m) | $359.54M | -2.89% |
| 2023-06-30 | $-20.85M | $1.63B | (m) | (m) | $331.50M | -1.28% |
| 2023-03-31 | $-3.92M | $1.48B | (m) | (m) | $300.06M | -0.26% |
| 2022-12-31 | $3.64M | $1.35B | (m) | (m) | $269.27M | 0.27% |
| 2022-09-30 | $-6.69M | $1.22B | (m) | $16.10M | $253.32M | -0.55% |
| 2022-06-30 | $-26.23M | $1.09B | (m) | (m) | $236.10M | -2.41% |
| 2022-03-31 | $-29.26M | $989.94M | (m) | $16.20M | $219.84M | -2.96% |
| 2021-12-31 | $-42.41M | $907.96M | (m) | $15.50M | $219.50M | -4.67% |
| 2021-09-30 | $-33.45M | $931.52M | (m) | (m) | $223.43M | -3.59% |
| 2021-06-30 | $-43.32M | $973.64M | (m) | (m) | $224.51M | -4.45% |
| 2021-03-31 | $-261.48M | $990.22M | (m) | (m) | $229.10M | -26.41% |
| 2020-12-31 | $-270.62M | $1.02B | (m) | $15.10M | $222.60M | -26.47% |
| 2020-09-30 | $-485.27M | $987.03M | (m) | (m) | $217.44M | -49.16% |
| 2020-06-30 | $-487.70M | $942.59M | (m) | (m) | $220.49M | -51.74% |
| 2020-03-31 | $-285.47M | $895.91M | (m) | (m) | $236.91M | -31.86% |
| 2019-12-31 | $-306.61M | $846.38M | (m) | $19.80M | $257.05M | -36.23% |
| 2019-09-30 | $-105.37M | $802.96M | (m) | (m) | $263.50M | -13.12% |
| 2019-06-30 | $-96.26M | $732.77M | (m) | (m) | $264.26M | -13.14% |
| 2019-03-31 | $-79.99M | $685.11M | (m) | (m) | $254.73M | -11.68% |
| 2018-12-31 | $-47.48M | $627.06M | (m) | $18.20M | $235.42M | -7.57% |
| 2018-09-30 | $-52.38M | (m) | (m) | (m) | $227.69M | (m) |
| 2018-06-30 | $-55.37M | (m) | (m) | (m) | $213.96M | (m) |
| 2018-03-31 | $-65.52M | (m) | (m) | (m) | $207.65M | (m) |
| 2017-12-31 | $-72.84M | (m) | (m) | $17.20M | $205.67M | (m) |
| 2017-09-30 | $-88.47M | (m) | (m) | (m) | $208.06M | (m) |
| 2017-06-30 | $-90.28M | (m) | (m) | (m) | $200.63M | (m) |
| 2017-03-31 | $-83.80M | (m) | (m) | (m) | $182.30M | (m) |
| 2016-12-31 | $-237.42M | (m) | (m) | $11.10M | $160.69M | (m) |
| 2016-09-30 | $-217.73M | (m) | (m) | (m) | $135.47M | (m) |
| 2016-06-30 | $-219.61M | (m) | (m) | (m) | $127.32M | (m) |
| 2016-03-31 | $-218.15M | (m) | (m) | (m) | $107.38M | (m) |
| 2015-12-31 | $-42.97M | (m) | (m) | $5.80M | $75.29M | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | (m) | (m) | $0.00 | $0.00 | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-21.16M | (m) | (m) | $2.00M | $15.60M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |